| Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment M Elahy, C Jackaman, JCL Mamo, V Lam, SS Dhaliwal, C Giles, D Nelson, ... Immunity & Ageing 12, 1-9, 2015 | 298 | 2015 |
| IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2 C Jackaman, CS Bundell, BF Kinnear, AM Smith, P Filion, D van Hagen, ... The Journal of Immunology 171 (10), 5051-5063, 2003 | 242 | 2003 |
| Aging and cancer: The role of macrophages and neutrophils C Jackaman, F Tomay, L Duong, NBA Razak, FJ Pixley, P Metharom, ... Ageing research reviews 36, 105-116, 2017 | 220 | 2017 |
| Targeting macrophages rescues age‐related immune deficiencies in C57 BL/6J geriatric mice C Jackaman, HG Radley‐Crabb, Z Soffe, T Shavlakadze, MD Grounds, ... Aging cell 12 (3), 345-357, 2013 | 145 | 2013 |
| Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo C Jackaman, D Majewski, SA Fox, AK Nowak, DJ Nelson Cancer Immunology, Immunotherapy 61, 2343-2356, 2012 | 105 | 2012 |
| Rescue of skeletal muscle α-actin–null mice by cardiac (fetal) α-actin KJ Nowak, G Ravenscroft, C Jackaman, A Filipovska, SM Davies, EM Lim, ... Journal of cell biology 185 (5), 903-915, 2009 | 95 | 2009 |
| Deliberately provoking local inflammation drives tumors to become their own protective vaccine site C Jackaman, AM Lew, Y Zhan, JE Allan, B Koloska, PT Graham, ... International immunology 20 (11), 1467-1479, 2008 | 77 | 2008 |
| Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies G Ravenscroft, C Jackaman, S Bringans, JM Papadimitriou, LM Griffiths, ... Brain 134 (4), 1101-1115, 2011 | 67 | 2011 |
| CD40‐activated B cells contribute to mesothelioma tumor regression C Jackaman, S Cornwall, PT Graham, DJ Nelson Immunology and cell biology 89 (2), 255-267, 2011 | 61 | 2011 |
| Chronic stress and A lzheimer's disease: the interplay between the hypothalamic–pituitary–adrenal axis, genetics and microglia A Milligan Armstrong, T Porter, H Quek, A White, J Haynes, C Jackaman, ... Biological Reviews 96 (5), 2209-2228, 2021 | 60 | 2021 |
| Dissociated flexor digitorum brevis myofiber culture system—a more mature muscle culture system G Ravenscroft, KJ Nowak, C Jackaman, S Clément, MA Lyons, ... Cell motility and the cytoskeleton 64 (10), 727-738, 2007 | 60 | 2007 |
| Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration A Crowe, C Jackaman, KM Beddoes, B Ricciardo, DJ Nelson PLoS One 8 (8), e73684, 2013 | 52 | 2013 |
| Macrophage function in the elderly and impact on injury repair and cancer L Duong, HG Radley, B Lee, DE Dye, FJ Pixley, MD Grounds, DJ Nelson, ... Immunity & Ageing 18, 1-11, 2021 | 49 | 2021 |
| Murine mesothelioma induces locally-proliferating IL-10+TNF-α+CD206−CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or … C Jackaman, TL Yeoh, ML Acuil, JK Gardner, DJ Nelson Oncoimmunology 5 (6), e1173299, 2016 | 49 | 2016 |
| Multiple Osmotic Stress Responses in Acidihalobacter prosperus Result in Tolerance to Chloride Ions M Dopson, DS Holmes, M Lazcano, TJ McCredden, CG Bryan, ... Frontiers in Microbiology 7, 2132, 2017 | 48 | 2017 |
| Macrophage depletion in elderly mice improves response to tumor immunotherapy, increases anti-tumor T cell activity and reduces treatment-induced cachexia L Duong, HG Radley-Crabb, JK Gardner, F Tomay, DE Dye, MD Grounds, ... Frontiers in Genetics 9, 526, 2018 | 43 | 2018 |
| Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function JK Gardner, CDS Mamotte, P Patel, TL Yeoh, C Jackaman, DJ Nelson PloS one 10 (4), e0123563, 2015 | 43 | 2015 |
| Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T‐and B‐cell zones F Tomay, K Wells, L Duong, JW Tsu, DE Dye, HG Radley‐Crabb, ... Immunology and cell biology 96 (8), 831-840, 2018 | 41 | 2018 |
| Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses C Jackaman, DJ Nelson Cancer Immunology, Immunotherapy 61, 549-560, 2012 | 38 | 2012 |
| Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells C Jackaman, S Cornwall, AM Lew, Y Zhan, BWS Robinson, DJ Nelson European Respiratory Journal 34 (1), 162-175, 2009 | 36 | 2009 |
